AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: December 2022 Quarterly Activities Report & Appendix 4C, page-7

  1. 2,782 Posts.
    lightbulb Created with Sketch. 496
    Not only no mention of the Team Saas arrangement status the following was also offered up in relation to the company's delicate cash position.
    "The Company’s Q4 spend included annual insurance premiums to cover the
    Company for the next twelve (12 months). These insurance premiums significantly increased
    the administration expenses during Q4 but will not be incurred again until Q4 2023".

    Manufacturing costs for the past Q4 were only $49K which really says it all.
    Very disappointing when only a short while ago the cash position was reported as N/A.
    Kens
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $3.607K 1.445M

Buyers (Bids)

No. Vol. Price($)
59 102396408 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 21041400 12
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.